MannKind shares may 'overshoot to the upside,' says JPMorgan JPMorgan believes shares of MannKind may "overshoot to the upside" following the positive FDA panel vote given the significant short interest in the name as well as the company’s "passionate" retail following. JPMorgan remains concerned about the commercial potential of Afrezza and keeps a Neutral rating on MannKind.
News For MNKD From The Last 14 Days
Check below for free stories on MNKD the last two weeks.
Stocks with call strike movement; MNKD SUNE MannKind (MNKD) January 17 call option implied volatility increased 6% to 79, SunEdison (SUNE) October 28 call option implied volatility increased 3% to 58 according to IVolatility.